title: [Management of a choroidal neovascular membrane with aflibercept in a patient with a rare, autosomal dominant late-onset retinal degeneration: case report].
authors.affiliation: Service d'ophtalmologie, CHU de Pointe-à-Pitre, route de Chauvel, BP 465, 97159 Pointe-à-Pitre cedex, Guadeloupe. Electronic address: y.troumani@gmail.com.
authors.forename: Y
authors.initials: Y
authors.lastname: Troumani
authors.affiliation: Service d'ophtalmologie, CHU de Pointe-à-Pitre, route de Chauvel, BP 465, 97159 Pointe-à-Pitre cedex, Guadeloupe.
authors.forename: L
authors.initials: L
authors.lastname: Beral
authors.affiliation: Service d'ophtalmologie, CHU de Pointe-à-Pitre, route de Chauvel, BP 465, 97159 Pointe-à-Pitre cedex, Guadeloupe; UFR des sciences médicales, faculté de médecine Antilles-Guyane Hyacinthe Bastaraudn, campus de Fouillole, BP 145, 97154 Pointe-à-Pitre cedex, Guadeloupe.
authors.forename: T
authors.initials: T
authors.lastname: David
mesh_terms: D000368:Aged; D020256:Choroidal Neovascularization / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D008297:Male; D035583:Rare Diseases; D040262:Receptors, Vascular Endothelial Growth Factor / Q000627:therapeutic use*; D011993:Recombinant Fusion Proteins / Q000627:therapeutic use*; D012162:Retinal Degeneration / Q000150:complications* / Q000235:genetics
chemical_list: D011993:Recombinant Fusion Proteins; C533178:aflibercept; D040262:Receptors, Vascular Endothelial Growth Factor